DRDO's anti-Coronavirus medicine 2-DG launched, here is what Dr Harsh Vardhan said

The first batch of DRDO-developed anti-Covid drug 2-DG (2-deoxy-D-glucose) an anti-Covid-19 therapeutic application of the drug developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of Defence Research and Development Organisation (DRDO) in collaboration with Dr Reddy's Laboratories (DRL) has been launched today.

Rajnath Singh handed over the anti-Covid drug to his cabinet colleague Harsh Vardhan who gave it to Delhi All India Institute of Medical Sciences (AIIMS) director Randeep Guleria at an event here.